UCA1 and serous adenocarcinoma: Interestingly, one study demonstrated UCA1 as a super-enhancer-associated gene, particularly sensitive to treatment with the BET inhibitor (+)-JQ1 in the high-grade serous adenocarcinoma CaOV3 and UWB1.289 cells [57].